Clinical trials: Axial or Predominantly Axial SpondyloArthritis With or Without Psoriasis
Axial or Predominantly Axial SpondyloArthritis With or Without Psoriasis
Evaluation of the Efficacy and Safety of Bimekizumab (BZK) or Adalimumab (ADA) in the Treatment of Anterior Chest Wall Pain Associated With Active Axial Spondyloarthritis Refractory to NSAIDs With Hypothesis of Superiority of Bimekizumab
The primary objective is to demonstrate the superiority of BKZ (dual inhibition of IL-17A and IL-17F) on the ASAS40 response at 6 months compared to a reference treatment (ADA) in patients with active axial or predominantly axial…
- Trial name
- ThoracSPA (NCT07836283)
- Testing
- bimekizumab, adalimumab
- Where
- France
- Volunteers
- 150 people
- Sponsor
- University Hospital, Rouen